271 (PB-095) Poster - Morphometric analysis of ductal carcinoma in situ identifies features associated with low risk of progression to invasive breast cancer

Autor: Leite, M., Melillo, X., Lam, N., Vonk, S., de Bruijn, B., Sanders, J., Almekinders, M., Visser, L., Groen, E., Van der Borden, C., Mulder, L., Kristel, P., Lips, E., Wesseling, J., Precision, T.

Publikováno v: In European Journal of Cancer November 2022 175 Supplement 1:S90-S90

Artificial intelligence-based morphometric signature to identify ductal carcinoma in situ with low risk of progression to invasive breast cancer.

Autor: Sobral-Leite M; Netherlands Cancer Institute., Castillo S; The University of Texas MD Anderson Cancer Center., Vonk S; Netherlands Cancer Institute., Melillo X; Netherlands Cancer Institute., Lam N; Netherlands Cancer Institute., de Bruijn B; Netherlands Cancer Institute., Hagos Y; The Institute of Cancer Research., Sanders J; Netherlands Cancer Institute., Almekinders M; Netherlands Cancer Institute., Visser L; Netherlands Cancer Institute., Groen E; Netherlands Cancer Institute., Kristel P; Netherlands Cancer Institute., Ercan C; The University of Texas MD Anderson Cancer Center., Azarang L; Netherlands Cancer Institute., Yuan Y; The Institute of Cancer Research, London., Menezes R; Netherlands Cancer Institute., Lips E; Netherlands Cancer Institute., Wesseling J; Netherlands Cancer Institute.

Publikováno v: Research square [Res Sq] 2023 Dec 13. Date of Electronic Publication: 2023 Dec 13.